Published in Cancer Med on October 05, 2016
Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov (2002) 6.13
Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. J Clin Oncol (2009) 5.70
Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol (2001) 5.09
Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol (2010) 3.80
Protein-binding assays in biological liquids using microscale thermophoresis. Nat Commun (2010) 3.37
The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. Trends Cell Biol (1999) 3.15
Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast Ipl1. J Biol Chem (1997) 2.44
New approaches to molecular cancer therapeutics. Nat Chem Biol (2006) 2.28
Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg (2004) 1.77
Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property. Mol Cell Biol (2005) 1.67
Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients. Mol Cancer Ther (2006) 1.28
GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models. Mol Cancer Ther (2009) 1.27
Cdc20 associates with the kinase aurora2/Aik. Proc Natl Acad Sci U S A (1999) 1.25
Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells. Mol Cancer Ther (2008) 1.21
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability. Br J Cancer (2005) 1.07
Downregulation of an AIM-1 kinase couples with megakaryocytic polyploidization of human hematopoietic cells. J Cell Biol (2001) 1.06
Quercetin: a pleiotropic kinase inhibitor against cancer. Cancer Treat Res (2014) 1.00
VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma. Am J Transl Res (2010) 0.98
The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer (2010) 0.98
Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancer. Lung Cancer (2013) 0.97
Aurora B: a new prognostic marker and therapeutic target in cancer. Curr Med Chem (2011) 0.97
Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 - 2013). Expert Opin Ther Pat (2014) 0.94
Identification of an Aurora kinase inhibitor specific for the Aurora B isoform. Cancer Res (2012) 0.89
Betulinic acid as a potent and complex antitumor phytochemical: a minireview. Anticancer Agents Med Chem (2014) 0.87
Predicting resistance by selection of signaling pathways. Transl Lung Cancer Res (2014) 0.82
Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152). Invest New Drugs (2011) 0.81
Quercetin Down-regulates IL-6/STAT-3 Signals to Induce Mitochondrial-mediated Apoptosis in a Nonsmall- cell Lung-cancer Cell Line, A549. J Pharmacopuncture (2015) 0.80
Protective effects of curcumin and quercetin during benzo(a)pyrene induced lung carcinogenesis in mice. Eur Rev Med Pharmacol Sci (2015) 0.80
3,6,2',4',5'-Pentahydroxyflavone, an orally bioavailable multiple protein kinase inhibitor, overcomes gefitinib resistance in non-small cell lung cancer. J Biol Chem (2014) 0.80
Effect of quercetin on chronic enhancement of spatial learning and memory of mice. Sci China C Life Sci (2006) 0.80
Aurora B Overexpression Causes Aneuploidy and p21Cip1 Repression during Tumor Development. Mol Cell Biol (2015) 0.80
Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B. Carcinogenesis (2012) 0.79
The role of Aurora B expression in non-tumor liver tissues of patients with hepatocellular carcinoma. Int J Clin Oncol (2013) 0.79
A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors. Invest New Drugs (2014) 0.78
[Mechanisms for quercetin in prevention of lung cancer cell growth and metastasis]. Zhong Nan Da Xue Xue Bao Yi Xue Ban (2015) 0.77
Curcumin and quercetin trigger apoptosis during benzo(a)pyrene-induced lung carcinogenesis. Mol Cell Biochem (2014) 0.77
Quercetin Enhances Chemosensitivity to Gemcitabine in Lung Cancer Cells by Inhibiting Heat Shock Protein 70 Expression. Clin Lung Cancer (2015) 0.77
Quercetin protects RAW264.7 macrophages from glucosamine-induced apoptosis and lipid accumulation via the endoplasmic reticulum stress pathway. Mol Med Rep (2015) 0.77
Quercetin suppresses NLRP3 inflammasome activation and attenuates histopathology in a rat model of spinal cord injury. Spinal Cord (2016) 0.77
Knockdown of Aurora-B inhibits the growth of non-small cell lung cancer A549 cells. Oncol Lett (2015) 0.77